NEWS IN BRIEF

Biologics CDMO completes €5m expansion in Spain

By Staff Reporter

- Last updated on GMT

(Image: Getty/ilbusca)
(Image: Getty/ilbusca)

Related tags: Contract manufacturing organisation, Spain

Biologics and cell therapy CDMO, 3P Biopharmaceuticals, has expanded its facility and capabilities in Pamplona, Spain.

The €5m ($5.6m) project has seen 3P Biopharmaceuticals expand its good manufacturing practice (GMP) bacteria area, and install a 50L single-use bioreactor for mammalian cell culture within the facility.

“This provides an attractive option for small batch manufacture as well as for intermediate cell expansion,” ​according to the firm.

The Spanish Agency of Medicines and Medical Devices has GMP-certified the new facilities.

3P has also adopted Sartorius Stedim Biotech’s ambr 250, a single-use multi-parallel bioreactor, which it said enables the development of 24 different experiments concurrently: “This capacity facilitates rapid decision-making for future manufacturing processes.”

“Furthermore, this technology strengthens the capacity of 3P to carry our process characterisation activities – an essential phase to drive the drug to market,” ​the firm added.

The contract development and manufacturing organisation (CDMO) has hired more than 50 staff members this year, and expects the business to expand to at least 245 by the end of 2019.

Related news

Related products

show more

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 22-Jul-2019 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Related suppliers

Follow us

Products

View more

Webinars